
These newly approved Rx products should appear in your pharmacy soon, if they haven't already.
These newly approved Rx products should appear in your pharmacy soon, if they haven't already.
Antibodies critical to stopping spread of viral cells.
Study examines history of universal health care in the United States.
Protein AKAP4 identified as the most accurate way to detect non-small cell lung cancer.
Study finds that mitochondria of tumor cells are critical to survival and proliferation.
The FDA has identified 11 cases of pulmonary hypertension in infants and newborns treated with diazoxide (Proglycem).
Six patient deaths and other serious adverse events have been linked to SentreHeart's Lariat Suture Delivery Device, the FDA is warning health care professionals.
Wait times for care negatively impacts patient health.
Researchers evaluate why early trials of dasatinib did not give conclusive results.
Mylan is urging health care professionals to check their inventories for certain lots of calcium chloride intravenous infusion prefilled syringes that were withdrawn from the market in April.
Includes evidence-based advice on the best use for next generation direct-acting antivirals.
Teva has launched the first generic version of Janssen's Axert migraine treatment.
Patients who received secukinumab sustained improvements over one year of treatment.
The FDA is requiring all non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) to include strengthened label warnings describing how the painkillers increase the odds of heart attack or stroke.
Access is open to US adult patients who are refractory to the most common anti-myeloma drug classes.
Multiple myeloma patients in immediate need of new treatment options can receive Janssen's investigational daratumumab through an expanded access program (EAP).
MM41 targets cell nuclei to provide a new method of attacking pancreatic cancer.
Restoration of miR-29 in cancer stromal cells helped decrease cancer growth.
Treatment could make existing cancer drugs more effective.
Teva has launched a generic version of aspirin and extended-release dipyridamole (Aggrenox) capsules in the United States.
Study finds current efforts are not enough to decrease the spread of infection.
Health care professionals should stop using dosing cups that measure in drams.
Monitoring activity in a protein could be crucial to detecting cancer early on.
Professors who provide pre-lecture diagrams can help their students retain more information in large classroom settings.
Combination of immunotherapy and epigenetics put patients into remission, even after failing the standard treatment.
The belief that math ability is developed through learning, also known as a growth mindset, may motivate more women to pursue careers in physics, engineering, mathematics, and computer science.
The FDA has added a new warning to the drug label of the methylphenidate transdermal system indicated for ADHD to describe permanent loss of skin color, also known as chemical leukoderma.
Glatopa treats patients with relapsing forms of multiple sclerosis.
The FDA is amending regulations for infant formula to add the selenium to the list of required nutrients.
Sandoz has begun shipping glatiramer acetate (Glatopa), the first FDA-approved generic competitor to Teva's Copaxone multiple sclerosis (MS) drug.